by Backoffice | Feb 27, 2022 | Collaborations
Cell2Cure has entered into a collaboration agreement with Endeavour Cells ApS, to collaborate on the preparation, conduct, management, and completion of an un-blinded phase I/II clinical trial in children with autism. The clinical trial title is “Effect of adipose...
by Backoffice | Feb 12, 2022 | Collaborations
Cell2Cure has entered into a sublicense agreement with Endeavour Cells ApS, which will allow Endeavour Cells ApS to develop, manufacture and commercialize ASCs for the treatment of Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD),...
